Charles McWherter

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Charles McWherter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles McWherter:

Form 4 holding Director

89bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
30 Oct 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President of R&D

CymaBay Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
22 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Charles McWherter

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .